Literature DB >> 2137797

Midluteal gonadotropin-releasing hormone analog administration in early pregnancy.

R Ron-El1, A Golan, A Herman, A Raziel, Y Soffer, E Caspi.   

Abstract

The incidence of GnRH-analog administration in the presence of undiagnosed pregnancy is discussed. Immediate hormonal supplementation avoids luteolysis. The report includes two cases, one without hormonal replacement, in which preclinical pregnancy occurred, and the second, where P was supplemented immediately upon diagnosis of pregnancy.

Mesh:

Substances:

Year:  1990        PMID: 2137797     DOI: 10.1016/s0015-0282(16)53361-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Inadvertent exposure of early pregnancy to gonadotropin releasing hormone analogue.

Authors:  A Shulman; M Shilon; C Bahary; J Dor; A Ellenbogen; S Mashiach
Journal:  J Assist Reprod Genet       Date:  1993-07       Impact factor: 3.412

2.  Outcome of pregnancies inadvertently exposed to gonadotropin-releasing hormone analogues (GnRH-a) in early gestation.

Authors:  Y Gonen; M Dirnfeld; H Abramovici
Journal:  J Assist Reprod Genet       Date:  1993-08       Impact factor: 3.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.